To explore the antiarrhythmic property of WXKL in cardiac Purkinje cells (PCs).
PCs were isolated from rabbit hearts and action potentials (APs) and ion currents were recorded by whole-cell patch clamp technique. Anemonia toxin II (ATX-II) and isoproterenol (ISO) were used to induce early or delayed afterdepolarizations (EADs, DADs) or triggered activities (TAs).
WXKL (1 g/L and 5 g/L) significantly abbreviated the action potential duration (APD) of PCs in a dose- and rate-dependent manner. Treatment of PCs with ATX-II (2 nM) prolonged APD and induced EADs, which were significantly suppressed by WXKL. WXKL (1, 5 g/L) also inhibited ISO-induced EADs, DADs, and TAs. To reveal the ionic mechanisms, we studied the effects of WXKL on late sodium current (INaL), peak sodium current (INaP), and L-type calcium currents (ICaL) in PCs. WXKL-attenuated ATX-II (5 nM) induced INaL augmentation and blocked INaL with an IC50 of 4.3 ± 0.5 g/L, which is 3- to 4-fold more selective than that of INaP (13.3 ± 0.9 g/L) and ICaL (17.6 ± 1.4 g/L). Moreover, WXKL exerted significantly less use-dependent block of INaP than that of flecainide, indicating its lower proarrhythmic effect.
WXKL exhibits antiarrhythmic properties in cardiac PCs via selective inhibition of INaL.